The relationship between hypotonically-induced taurine and K fluxes in trout red blood cells.
Hypotonic swelling of teleost erythrocytes activates multiple transport systems leading to the regulatory decrease of cell volume. We have examined using pharmacological manipulation the swelling-induced taurine flux pathway in red blood cells of the rainbow trout and its relationship to swelling-induced K flux pathways. We show that the activation and deactivation of taurine flux is rapid and that the flux is a sigmoidal function of cell volume. N-ethylmaleimide (NEM) and the non-specific protein kinase inhibitor, staurosporine, both inactivated the hypotonically-induced taurine flux with concentrations eliciting half-maximal inhibition (IC50s) of 212 and 17 micromol(-1), respectively. The low taurine fluxes under isotonic conditions were unaffected. By contrast, the tyrosine kinase inhibitor, genistein, partially inhibited taurine flux under both isotonic and hypotonic conditions. The specific phosphatase inhibitor, calyculin A, had no inhibitory or stimulatory effect under either condition whilst the less-specific phosphatase inhibitor, ortho-vanadate, reduced taurine flux only under hypotonic conditions. In these respects the regulatory control of the taurine pathway differs from the Cl-dependent K flux. However, NEM and staurosporine also inhibited the Cl-independent K flux, both with similar IC50s to those observed for taurine fluxes. This supports the idea of the hypotonically-induced taurine flux and the Cl-independent K flux sharing the same transport pathway.
Kiessling
K
K
University Laboratory of Physiology, University of Oxford, UK.
Ellory
J C
JC
Cossins
A R
AR
D000818:Animals; D001692:Biological Transport / Q000187:drug effects / Q000502:physiology; D048429:Cell Size / Q000187:drug effects / Q000502:physiology; D002712:Chlorides / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D005033:Ethylmaleimide / Q000494:pharmacology; D007038:Hypotonic Solutions / Q000494:pharmacology*; D008387:Marine Toxins; D017686:Oncorhynchus mykiss; D009994:Osmolar Concentration; D010080:Oxazoles / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism*; D012964:Sodium / Q000378:metabolism; D019311:Staurosporine / Q000494:pharmacology; D013654:Taurine / Q000378:metabolism*
D002712:Chlorides; D004791:Enzyme Inhibitors; D007038:Hypotonic Solutions; D008387:Marine Toxins; D010080:Oxazoles; D013654:Taurine; C059041:calyculin A; D012964:Sodium; D019311:Staurosporine; D005033:Ethylmaleimide; D011188:Potassium